Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

1.0K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.0K
Schizophrenia01:17

Schizophrenia

838
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
838
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

535
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
535
Review and Preview01:10

Review and Preview

8.3K
In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
8.3K
Review and Preview01:13

Review and Preview

10.9K
Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
10.9K
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

495
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
495

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Co-expression-based models improve eQTL predictions for transcriptome-wide association studies and highlight new schizophrenia-associated genes.

Nature genetics·2026
Same author

Benchmarking functional brain network organization in childhood and its similarity to adults.

Frontiers in neuroimaging·2026
Same author

Transdiagnostic Profiles of BOLD Signal Variability in Autism and Schizophrenia Spectrum Disorders: Associations With Cognition and Functioning.

Human brain mapping·2026
Same author

Microstructural Alterations of the Cerebellum-Ventral Tegmental Area Pathways in First-Episode Psychosis.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2026
Same author

Multivariate relationships between social cognitive performance and functional connectivity during task and rest across schizophrenia spectrum disorders and healthy controls.

Molecular psychiatry·2026
Same author

Clozapine treatment in the early stages of schizophrenia.

Current opinion in psychiatry·2026

Related Experiment Video

Updated: Jan 23, 2026

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

10.3K

Electroconvulsive Therapy and Schizophrenia: A Systematic Review.

Sana A Ali1, Nandita Mathur1, Anil K Malhotra1,2,3

  • 1Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, New York, New York, USA.

Molecular Neuropsychiatry
|June 14, 2019
PubMed
Summary

Electroconvulsive therapy (ECT) is effective for schizophrenia treatment, though cognitive side effects require careful consideration. Research explores its use in severe mental illness and potential biomarker applications.

Keywords:
BiomarkersElectroconvulsive therapySchizophreniaTreatment

More Related Videos

The Optical Fractionator Technique to Estimate Cell Numbers in a Rat Model of Electroconvulsive Therapy
07:55

The Optical Fractionator Technique to Estimate Cell Numbers in a Rat Model of Electroconvulsive Therapy

Published on: July 9, 2017

12.1K
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.4K

Related Experiment Videos

Last Updated: Jan 23, 2026

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

10.3K
The Optical Fractionator Technique to Estimate Cell Numbers in a Rat Model of Electroconvulsive Therapy
07:55

The Optical Fractionator Technique to Estimate Cell Numbers in a Rat Model of Electroconvulsive Therapy

Published on: July 9, 2017

12.1K
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.4K

Area of Science:

  • Psychiatry
  • Neuroscience
  • Clinical Psychology

Background:

  • Electroconvulsive therapy (ECT) is highly effective for major depressive disorder.
  • ECT utilization for psychotic disorders, including schizophrenia, is less common.
  • Emerging evidence suggests ECT's utility in treatment-resistant schizophrenia.

Purpose of the Study:

  • To review the efficacy of ECT in schizophrenia.
  • To assess ECT's impact on cognitive function in schizophrenia patients.
  • To explore maintenance ECT and neuroimaging biomarkers for personalized ECT strategies.

Main Methods:

  • Systematic review of existing literature.
  • Emphasis on prospective, randomized controlled trials.
  • Analysis of safety, efficacy, and cognitive effects of ECT in schizophrenia.

Main Results:

  • ECT demonstrates effectiveness as a treatment strategy for schizophrenia.
  • ECT is a safe modality, but cognitive impairment potential must be managed.
  • Biomarker research for pharmacological treatments may extend to ECT.

Conclusions:

  • ECT is a viable and effective treatment option for schizophrenia.
  • Balancing ECT's benefits against cognitive risks is crucial.
  • Future research should focus on biomarkers to optimize ECT in schizophrenia.